Pipeline

bonus 1a

Product Candidate

Preclinical R&D

Phase I

Phase II

Phase III

MesenCure for respiratory distress

Phase III

BonoFill for facial bone deficiencies

Phase II

BonoFill for treating critical bone defects in the limbs

Phase II

MesenCure for treating other inflammations and tissue damage

Preclinical R&D

BonoFill for bone augmentation in osteoporosis

Preclinical R&D

Vascularized bone grafts

Preclinical R&D

Soft tissue grafts

Preclinical R&D

Standing at the forefront of regenerative medicine, we harness unparalleled knowledge and innovative technologies to unlock the full potential of therapeutic cells. Our unique technological platform revolutionizes cell therapy and tissue engineering, offering a unique capacity to address a broad spectrum of diseases involving tissue damage and inflammation.

bonus 1a

Image

CELL THERAPY

Our cell therapies represent a living pharmacy, capable of deploying multiple therapeutics simultaneously, offering a more comprehensive treatment approach than single-drug therapies.

Image

TISSUE ENGINEERING

It takes a village to grow a tissue, and one kind of cell is rarely enough.

 

INFORMATION FOR INVESTORS  |  CAREER OPPORTUNITIES  |  INFORMATION FOR PATIENTS   |   RESEARCH COLLABORATIONS & BUSINESS DEVELOPMENT INQUIRIES

INFORMATION FOR INVESTORS

CAREER OPPORTUNITIES

INFORMATION FOR PATIENTS

RESEARCH COLLABORATIONS & BUSINESS DEVELOPMENT INQUIRIES

MAIL ICON  info@bonus-bio.com

MAIL ICON  +972 (0)73 206 7104

MAIL ICONMatam Advanced Technology
Park P.O.B 15143 Haifa 31905 Israel

you tube linkedin facebook twitter

© 2022 Bonus BioGroup Ltd. Created By Netron Israel Ltd

Please publish modules in offcanvas position.